Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Myleran

Known as: Myléran 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1987
Highly Cited
1987
Adult male mice were treated with one or two different doses of each of 18 different cytotoxic agents. They were sampled at… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
1986
Review
1986
Busulfan is a bifunctional alkylating agent that appears to be cytotoxic to slowly proliferating or non-proliferating stem cell… Expand
1979
1979
The comparative metabolism of the enantiomers of cyclo phosphamide and of the racemate has been studied in humans. Four patients… Expand
Highly Cited
1975
Highly Cited
1975
The sperm of (C57BL X C3H)F1 mice were examined 1, 4, and 10 weeks after a subacute treatment with one of 25 chemicals at two or… Expand
Review
1972
Review
1972
Development of side-effects after long-term treatment with busulfan is described in a 61-year-old woman with chronic myelogenous… Expand
1969
1969
The selectivity of action of alkylating agents and drug resistance. II. A comparison of the effects of alkylating drugs on growth… Expand
  • table I
  • table II
  • table III
Highly Cited
1960
Highly Cited
1960
A female infant, born of a mother with leukemia who received 6-mercaptopurine and x-ray therapy early in the pregnancy and… Expand
Highly Cited
1958
Highly Cited
1958
The chief role of 1,4-dimethanesulfonyloxybutane (busulfan, Myleran) is in the treatment of chronic granulocytic leukemia. The… Expand
Highly Cited
1958
Highly Cited
1958
ELSON (1955) has described the effects on the peripheral blood counts of the rat of a typical ‘nitrogen mustard’, chloranibucil… Expand
Highly Cited
1956
Highly Cited
1956
In the hope of finding a less toxic analogue of nitrogen mustard, Haddow replaced the methyl groups in the nitrogen mustard… Expand